Pain
News from the FDA/CDC
FDA issues new NSAIDs warning for second half of pregnancy
The FDA action expands on earlier warnings about agents in this drug class, which the FDA previously cautioned about taking after week 30 of...
Applied Evidence
Low back pain in youth: Recognizing red flags
Although low back pain in children and teens is usually benign, recognizing red flags that indicate the need for imaging, referral, bracing, or...
Commentary
Putting an end to chronic opioid prescriptions
We should not be starting people on opioids for knee and back pain.
Applied Evidence
Choosing Wisely: 10 practices to stop—or adopt—to reduce overuse in health care
The evidence-based recommendations presented here, made by the AAFP and other societies, can help you to avoid unnecessary testing and...
From the Journals
Children’s opioid harms vary by race, location
Analysis of North Carolina Medicaid data separates opioid-related poisoning or withdrawal from abuse or dependence.
Conference Coverage
Music’s charms may soothe heart failure’s effects
Evidence builds that music, either heard or sung, exerts measurable benefits for heart failure and other cardiovascular diseases.
From the Journals
‘Overwhelming evidence’ FDA’s opioid approval process is shoddy
The majority of approvals of opioids for the treatment of chronic pain during 1997-2018 were based on pivotal trials that lacked critical safety...
Photo Rounds
Recurrent leg lesions
News
FDA orders stronger warnings on benzodiazepines
"While benzodiazepines are important therapies for many Americans, they are also commonly abused and misused," said Commissioner Stephen M. Hahn,...
Commentary
New acute pain guidelines from the ACP and AAFP have limitations
Pain can be multi-factorial and treating it requires a multi-pronged approach.
News
Reworked OxyContin fails to cut overall opioid abuse, FDA panel says
Some members noted that reformulated OxyContin coincided with increased transition to heroin but recognized the difficulty of proving causality....